P3bep (Anzup 1302): An International Randomized Phase Iii Trial Of Accelerated Versus Standard Bep Chemotherapy For Male And Female Adults And Children With Intermediate And Poor-Risk Metastatic Germ Cell Tumors (Gcts).

Shalini Subramaniam,Guy C. Toner,Martin R. Stockler,Andrew James Martin,Farzana D. Pashankar,Ben Tran,Mark Jeffery,Danish Mazhar,Robert A Huddart,Euan Thomas Walpole,Amanda Gwendolyn Stevanovic,David Wyld,Fritha J. Hanning,Matthew James Wheater, Jay R. Balagtas,Simon Troon,Alison Jane Birtle,Jeff D. White,Peter S. Grimison, New Zealand Urogenital

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 0|浏览12

暂无评分

摘要

TPS390Background: Bleomycin, etoposide, and cisplatin (BEP) given 3-weekly x 4 is standard first-line chemotherapy for metastatic GCT categorised as intermediate risk or poor risk. Acceleration of ...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要